Trial Condition(s):

Fever, Migraine, Pain

BAY81-8781 Thrombocyte inhibition, pharmacokinetics

Bayer Identifier:

12011

ClinicalTrials.gov Identifier:

Not Available

EudraCT Number:

2006-002057-77

EU CT Number:

Not Available

Study Completed

Trial Purpose

Primary Objective:
To investigate the function of platelets after different single doses of
acetylsalicylic acid (ASA) given as intravenous (IV) BAY 81-8781 and
Aspirin® tablets in comparison to inactive intravenous (IV) treatment.

Secondary Objective:
To investigate safety, tolerability, and pharmacokinetics of these
treatments.

Inclusion Criteria
No Inclusion Criteria Available
Exclusion Criteria
No Exclusion Criteria Available

Trial Summary

Enrollment Goal
22
Trial Dates
black-arrow
Phase
1
Could I receive a placebo?
No
Products
Aspirin (Acetylsalicylic Acid, BAY81-8781)
Accepts Healthy Volunteers
N/A

Where to Participate

Loading...
Locations
Status
LocationsStatus
Locations

Investigative Site

Wuppertal, Germany, 42096

Status
Completed

For details, please refer to trial results

Additional Information